EDIT — Editas Medicine, Inc.

EDITEditas Medicine, Inc.

NAS · US · Healthcare · Biotechnology · editasmedicine.com

2.905USD+5.25%Mkt Cap: 288.82M USDP/E: —Last update: 2026-05-26

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based …

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap288.82M USD

Enterprise Value155.06M USD

Revenue (TTM)38.69M USD

Gross Profit-42.27M USD

Net Income (TTM)-160.06M USD

Revenue/Share0.4190 USD

Last Price2.905 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees87

CountryUS

SectorHealthcare

IndustryBiotechnology

ISINUS28106W1036

Valuation

P/E (Trailing)—

P/E (Forward)-2.95

PEG—

EV/EBITDA-1.82

EV/Revenue4.01

P/S6.76

P/B59.33

EPS (TTM)-1.14

EPS (Forward)-0.91

52W Range

1.51046% of range4.537

52W High4.537 USD

52W Low1.510 USD

Profitability

Gross Margin-109.24%

Oper. Margin-883.19%

EBITDA Margin-220.16%

Profit Margin-395.01%

ROE-586.56%

ROA-85.81%

Growth

Revenue Growth-39.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF-165.24M USD

CapEx (TTM)607.00K USD

FCF Margin-190.77%

FCF Yield-25.56%

Net Debt-106.35M USD

Net Debt/EBITDA1.25

Balance Sheet

Debt/Equity0.66

Current Ratio3.22

Quick Ratio3.17

Book Value/Sh0.0450 USD

Cash/Share1.263 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating2.1 (Buy)

Target (Mean)5.778 USD

Target Range1.000 USD – 15.00 USD

# Analysts9

Ownership

Shares Out.97.91M

Float97.64M

Insiders0.31%

Institutions54.87%

Short Interest

Short Ratio6.3d

Short % Float10.25%

Short % Out.10.22%

Shares Short10.01M

Short (prev mo.)11.94M

Technical

SMA 502.807 (+3.5%)

SMA 2002.646 (+9.8%)

Beta2.14

S&P 52W Chg28.31%

Avg Vol (30d)1.45M

Avg Vol (10d)1.12M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—